FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

The drug is still new and not yet commercially available, but Dr. Boutwell hopes to get her hands on it in the next couple of months. (KCTV5) The drug is still new and not yet commercially available, but Dr. Boutwell hopes to get her hands on it in the next couple of months. (KCTV5)
























The drug is still new and not yet commercially available, but Dr. Boutwell hopes to get her hands on it in the next couple of months. (KCTV5)

A new drug is giving patients suffering from an aggressive form of MS new hope.

After living with MS for decades, Janet Franklin's condition is now considered to be primary progressive, which is one the most aggressive forms of the disease. 

"It’s affected my life to the point where I finally had to quit working and I’m using a scooter now primarily,” Franklin said.

Dr. Cristine Boutwell, director of the MS Center at St. Luke's Marion Bloch Neuroscience, says the disease is an auto-immune condition in which the body attacks itself.

But a breakthrough drug, called Ocrevus, has recently been approved by the Federal Drug Administration.

For the first time, a drug would offer patients with the primary progressive form of MS a new option.

While it’s not a cure for the disease, Boutwell says it's shown to slow down the progression of the disease, which could change the quality of life for her patients.

"It’s trying to slow down their disability progression and to reduce the problems in the neurologic disability that they have so that they can be productive citizens and lead productive lives and do everything that they want with their families and friends," Boutwell said.

For Franklin, that means looking forward to living out her life-long dream.


“I'm shooting to hopefully, if I ever become a grandmother, I would be able to carry a baby and not drop it," she said.

Story Source: The above story is based on materials provided by KCTV5
Note: Materials may be edited for content and length

Labels: , ,



Go to Newer News Go to Older News